Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
Organometallics, such as copper compounds, are cancer chemotherapeutics used alone or in combination with other drugs. One small group of copper complexes exerts an effective inhibitory action on topoisomerases, which participate in the regulation of DNA topology. Copper complexes inhibitors of topo...
Main Authors: | Caroline Molinaro, Alain Martoriati, Lydie Pelinski, Katia Cailliau |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/2863 |
Similar Items
-
A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas
by: Caroline Molinaro, et al.
Published: (2022-02-01) -
Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies
by: Caroline Molinaro, et al.
Published: (2021-07-01) -
Synthesis and Biological Activity of a New Indenoisoquinoline Copper Derivative as a Topoisomerase I Inhibitor
by: Caroline Molinaro, et al.
Published: (2023-09-01) -
DNA topoisomerases as molecular targets for anticancer drugs
by: Kamila Buzun, et al.
Published: (2020-01-01) -
The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy
by: Victor M. Matias-Barrios, et al.
Published: (2023-01-01)